USANA Health Sciences Inc (USNA) is not a strong buy at this moment for a beginner, long-term investor. The technical indicators suggest a bearish trend, and the company's financial performance shows significant declines in net income and EPS. While the company has positive news around its sponsorships and partnerships, these are not strong enough catalysts to offset the negative financial and technical signals.
The stock is in a bearish trend with MACD negatively expanding, RSI indicating an oversold condition at 17.613, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S2 support level of 17.106, with a post-market price of 17.83.

USANA-sponsored athletes won 28 medals at the 2026 Winter Olympics, strengthening brand visibility. The company continues its long-term partnership with US Speedskating, which has resulted in notable achievements.
The company's financial performance for Q4 2025 shows a significant decline in net income (-139.85% YoY) and EPS (-143.48% YoY). Gross margin also dropped by 4.62% YoY. Additionally, technical indicators and stock trends suggest bearish momentum.
In Q4 2025, revenue increased by 5.89% YoY to $226.2M. However, net income dropped significantly to -$1.775M (-139.85% YoY), and EPS fell to -0.1 (-143.48% YoY). Gross margin declined to 78.16 (-4.62% YoY).
No recent analyst rating or price target changes available.
